ArticleBriefings in bioinformatics2026
Mixture diffusion model for multimodal antibody design.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Antibody design requires modeling complementarity-determining region (CDR) loops that are highly flexible and adopt diverse conformations to achieve high-affinity antigen binding. Current diffusion-based generative models almost universally adopt unimodal distributions to parameterize sequence-structure transitions, which produce smooth conformations but constrain generation to a single conformational mode. This limitation impedes the exploration of alternative high-affinity binding conformations, particularly for challenging targets where exceptional binders may exist in low-probability regions of the conformational space. To address this, we introduce the mixture diffusion model for multimodal antibody design, a denoising diffusion probabilistic model that uses mixture density parameterizations for both positional and rotational updates. Through experiments on antibody-antigen complexes from the Structural Antibody Database (SAbDab), we find that increasing the number of mixture components improves model performance by capturing distinct canonical-like backbone conformations of CDRs. Our model achieves competitive amino acid recovery and binding-affinity-related metrics while maintaining physically consistent backbones. Through our results, we establish mixture-based diffusion modeling as a practical path toward discovering high-quality antibody conformations that remain inaccessible to conventional single-mode diffusion frameworks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.